Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03774966 · ClinicalTrials.gov registry record · Early Phase 1
IPACK and Adductor Canal Catheter Patient Outcomes for TKAs?
A Early Phase 1 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 60
- Enrollment target
NCT03774966 is a Early Phase 1 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 60 participants.
The verdict
NCT03774966, a Early Phase 1 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study evaluates the addition of the IPACK block to the adductor canal block and catheter in the pain management of total knee arthroplasty. Half of participants will receive the adductor canal block and catheter with the IPACK block, while the other half will receive the adductor canal block and catheter only.
Interventions
- PROCEDURE Adductor Canal Block + Catheter & IPACK block
- PROCEDURE Adductor canal block + catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-02-12 |
| Est. Completion | 2019-05-28 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03774966
The ClinicalTrials.gov registry entry for NCT03774966 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adductor Canal Block + Catheter & IPACK block is the first listed.
NCT03774966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03774966 about?
NCT03774966 is a clinical study titled "IPACK and Adductor Canal Catheter Patient Outcomes for TKAs?". This study evaluates the addition of the IPACK block to the adductor canal block and catheter in the pain management of total knee arthroplasty. Half of participants will receive the adductor canal block and catheter with the IPACK block, while the other half will receive the adductor canal block an...
What is the current status of trial NCT03774966?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 60 participants. The study started on 2019-02-12. Estimated completion is 2019-05-28.
What interventions are being tested in trial NCT03774966?
The interventions under investigation include: Adductor Canal Block + Catheter & IPACK block (PROCEDURE), Adductor canal block + catheter (PROCEDURE).
Who is sponsoring clinical trial NCT03774966?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.